RT Journal Article SR Electronic T1 SARS-CoV-2 Distribution in Residential Housing Suggests Contact Deposition and Correlates with Rothia sp JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.12.06.21267101 DO 10.1101/2021.12.06.21267101 A1 Cantú, Victor J A1 Salido, Rodolfo A. A1 Huang, Shi A1 Rahman, Gibraan A1 Tsai, Rebecca A1 Valentine, Holly A1 Magallanes, Celestine G. A1 Aigner, Stefan A1 Baer, Nathan A. A1 Barber, Tom A1 Belda-Ferre, Pedro A1 Betty, Maryann A1 Bryant, MacKenzie A1 Maya, Martin Casas A1 Castro-Martínez, Anelizze A1 Chacón, Marisol A1 Cheung, Willi A1 Crescini, Evelyn S. A1 Hoff, Peter De A1 Eisner, Emily A1 Farmer, Sawyer A1 Hakim, Abbas A1 Kohn, Laura A1 Lastrella, Alma L. A1 Lawrence, Elijah S. A1 Morgan, Sydney C. A1 Ngo, Toan T. A1 Nouri, Alhakam A1 Ostrander, R Tyler A1 Plascencia, Ashley A1 Ruiz, Christopher A. A1 Sathe, Shashank A1 Seaver, Phoebe A1 Shwartz, Tara A1 Smoot, Elizabeth W. A1 Valles, Thomas A1 Yeo, Gene W. A1 Laurent, Louise C. A1 Fielding-Miller, Rebecca A1 Knight, Rob YR 2021 UL http://medrxiv.org/content/early/2021/12/07/2021.12.06.21267101.abstract AB Monitoring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on surfaces is emerging as an important tool for identifying past exposure to individuals shedding viral RNA. Our past work has demonstrated that SARS-CoV-2 reverse transcription-quantitative PCR (RT-qPCR) signals from surfaces can identify when infected individuals have touched surfaces such as Halloween candy, and when they have been present in hospital rooms or schools. However, the sensitivity and specificity of surface sampling as a method for detecting the presence of a SARS-CoV-2 positive individual, as well as guidance about where to sample, has not been established. To address these questions, and to test whether our past observations linking SARS-CoV-2 abundance to Rothia spp. in hospitals also hold in a residential setting, we performed detailed spatial sampling of three isolation housing units, assessing each sample for SARS-CoV-2 abundance by RT-qPCR, linking the results to 16S rRNA gene amplicon sequences to assess the bacterial community at each location and to the Cq value of the contemporaneous clinical test. Our results show that the highest SARS-CoV-2 load in this setting is on touched surfaces such as light switches and faucets, but detectable signal is present in many non-touched surfaces that may be more relevant in settings such as schools where mask wearing is enforced. As in past studies, the bacterial community predicts which samples are positive for SARS-CoV-2, with Rothia sp. showing a positive association.Importance Surface sampling for detecting SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is increasingly being used to locate infected individuals. We tested which indoor surfaces had high versus low viral loads by collecting 381 samples from three residential units where infected individuals resided, and interpreted the results in terms of whether SARS-CoV-2 was likely transmitted directly (e.g. touching a light switch) or indirectly (e.g. by droplets or aerosols settling). We found highest loads where the subject touched the surface directly, although enough virus was detected on indirectly contacted surfaces to make such locations useful for sampling (e.g. in schools, where students do not touch the light switches and also wear masks so they have no opportunity to touch their face and then the object). We also documented links between the bacteria present in a sample and the SARS-CoV-2 virus, consistent with earlier studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by NIH grant (K01MH112436) to RFM, and the County of San Diego Health and Human Services Agency (Contract 563236). We thank Min Yi Wu, Bing Xia, Daniel Maunder, Michal Machnicki, Bhavika K. Kapadia, and Lizbeth Franco Vargas for their support with environmental SARS-CoV-2 detection as part of the EXCITE Lab. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Patients were recruited to the study via phone call, enrolled into an IRB-approved study (UCSD protocol 200477), and confirmed to be active UCSD students isolating in the isolation dorms.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequencing data produced are available online at https://qiita.ucsd.edu/study/description/13957 https://qiita.ucsd.edu/study/description/13957